TheraCryf Plc is a clinical stage drug development company, which engages in the development of pharmaceutical products and focus on cancer and neurological disease. Its pipeline includes SFX-01: Breast cancer, SFX-01: Subarachnoid Haemorrhage, and Other Programmes. The company was founded by Stephen Franklin in 2007 and is headquartered in Nether Alderley, CH.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company